What is the current valuation of the US virtual clinical-trials market?

The market valuation was $2604.0 Million in 2024. Read More

What is the projected market size for the US virtual clinical-trials market by 2035?

The projected valuation for 2035 is $5057.0 Million. Read More

What is the expected CAGR for the US virtual clinical-trials market during 2025 - 2035?

The expected CAGR during this period is 6.22%. Read More

Which companies are considered key players in the US virtual clinical-trials market?

Key players include Medidata Solutions, Oracle Corporation, Parexel International, Covance, Clinipace, Veeva Systems, WCG Clinical, and Science 37. Read More

What are the main segments of the US virtual clinical-trials market?

The main segments include Study Design, Technology, Therapeutic Area, and Participant Recruitment. Read More

How did interventional trials perform in the US virtual clinical-trials market?

Interventional trials had a valuation of $1040.0 Million in 2024 and are projected to reach $2100.0 Million. Read More

What is the valuation range for telemedicine platforms in the US virtual clinical-trials market?

Telemedicine platforms were valued at $1040.0 Million in 2024 and are expected to grow to $2080.0 Million. Read More

What is the projected growth for oncology trials in the US virtual clinical-trials market?

Oncology trials had a valuation of $1040.0 Million in 2024 and are anticipated to reach $2100.0 Million. Read More

How does the participant recruitment segment perform in the US virtual clinical-trials market?

The participant recruitment segment was valued at $780.0 Million in 2024 and is projected to grow to $1500.0 Million. Read More

What technological advancements are influencing the US virtual clinical-trials market?

Technologies such as wearable technology, mobile health applications, telemedicine platforms, and blockchain technology are driving growth. Read More

US Virtual Clinical Trials Market

US Virtual Clinical Trials Market Research Report: Size, Share, Trend Analysis By Study Type (Interventional, Observational, Others), By Phase (Phase 1, Phase 2, Phase 3, Phase 4) and By Indication (Oncology, Cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

6.22%

2024 Market Size

$ 2,604 Million

2035 Market Size

$ 5,057 Million

Healthcare Services ● Updated August 2026 Report ID: MRFR/HS/16124-HCR | Pages: 100 | Author: Vikita Thakur, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Study Design (USD Million)
  1. 4.1.1 Interventional Trials
  2. 4.1.2 Observational Trials
  3. 4.1.3 Registry Trials
  4. 4.1.4 Diagnostic Trials
2. 4.2 Chemicals and Materials, BY Technology (USD Million)
  1. 4.2.1 Wearable Technology
  2. 4.2.2 Mobile Health Applications
  3. 4.2.3 Telemedicine Platforms
  4. 4.2.4 Blockchain Technology
3. 4.3 Chemicals and Materials, BY Therapeutic Area (USD Million)
  1. 4.3.1 Oncology
  2. 4.3.2 Cardiology
  3. 4.3.3 Neurology
  4. 4.3.4 Infectious Diseases
  5. 4.3.5 Endocrinology
4. 4.4 Chemicals and Materials, BY Participant Recruitment (USD Million)
  1. 4.4.1 Direct to Patient
  2. 4.4.2 Doctor Referrals
  3. 4.4.3 Online Platforms
  4. 4.4.4 Patient Registries
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medidata Solutions (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Oracle Corporation (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Parexel International (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Covance (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Clinipace (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Veeva Systems (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 WCG Clinical (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Science 37 (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY STUDY DESIGN
3. 6.3 US MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 US MARKET ANALYSIS BY THERAPEUTIC AREA
5. 6.5 US MARKET ANALYSIS BY PARTICIPANT RECRUITMENT
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY STUDY DESIGN, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY STUDY DESIGN, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY THERAPEUTIC AREA, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY PARTICIPANT RECRUITMENT, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY PARTICIPANT RECRUITMENT, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY STUDY DESIGN, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Million)
  4. 7.2.4 BY PARTICIPANT RECRUITMENT, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Virtual Clinical Trials Market Segmentation

US Virtual Clinical Trials Market By Study Design (USD Million, 2025-2035)

Interventional Trials
Observational Trials
Registry Trials
Diagnostic Trials

US Virtual Clinical Trials Market By Technology (USD Million, 2025-2035)

Wearable Technology
Mobile Health Applications
Telemedicine Platforms
Blockchain Technology

US Virtual Clinical Trials Market By Therapeutic Area (USD Million, 2025-2035)

Oncology
Cardiology
Neurology
Infectious Diseases
Endocrinology

US Virtual Clinical Trials Market By Participant Recruitment (USD Million, 2025-2035)

Direct to Patient
Doctor Referrals
Online Platforms
Patient Registries

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”